Semaglutide improves kidney outcomes and survival in patients with type 2 diabetes and chronic kidney disease, regardless of baseline CVD risk.

An analysis shows that oral semaglutide significantly lowers the risk of heart failure (HF) outcomes in patients with type 2 diabetes and a history of HF. Heart failure (HF) is a major complication ...

Share on Pinterest Emerging evidence suggests that oral semaglutide may reduce the risk of heart failure–related events in people with type 2 diabetes. JasonDoiy/Getty Images Oral semaglutide may ...

Drinking up to five cups of coffee a day is safe for most adults, and regular coffee consumption may be linked to a lower ...

Scientists are digging into why heart disease risk in type 2 diabetes differs between men and women—and sex hormones may be part of the story. In a large Johns Hopkins study, men with higher ...

A new American Heart Association study found that drinking the equivalent of five cups of coffee a day may lower the risk of ...

Leading cardiovascular societies have developed the second universal definition of heart failure that updates how it is classified and identified, hoping to improve diagnosis and management.

Dr London emphasises moderation in coffee consumption for health benefits, noting that excess sugar and certain brewing ...

The SGLT2 inhibitor medicines have changed how heart failure is managed. Originally, sodium-glucose cotransporter 2 (SGLT2) inhibitors were used to lower blood sugar levels in people who have type 2 ...

Heart failure already affects more than 60 million people worldwide and is one of the leading causes of hospitalization among ...

NICE has recommended a nonsteroidal mineralocorticoid receptor antagonist that lowers worsening heart failure events in adults with preserved or mildly reduced ejection fraction.

A new study from the UC Davis School of Medicine found striking differences at the cellular level between male and female mice with heart failure with preserved ejection fraction (HFpEF). The findings ...